Sign up to save your podcasts
Or
Share An Epidural Letdown (4.4.2025)
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
An Epidural Letdown (4.4.2025)
Dr. Jack Cush reviews the news and journal reports from this past week on RheumNow.com.
**Correction: a Tweet from 3/18 podcast, had incorrect information. Late Breaking abstract from 2025 Amer. Acad. Dermatology (AAD) on the Phase 3 ICONIC-LEAD study showed J&J's oral IL-23 inhibitor (icotrokinra) was superior to PLACEBO (not deucravacitinib as reported) in skin clearance (65% vs 8%) & PASI90 (50% v 4%) at Wk 16 (NOT 15) in 684 moderate-to-severe plaque PsO pts https://buff.ly/dMbTbML
View all episodes
By Dr. Cush
4.7
121121 ratings
Dr. Jack Cush reviews the news and journal reports from this past week on RheumNow.com.
**Correction: a Tweet from 3/18 podcast, had incorrect information. Late Breaking abstract from 2025 Amer. Acad. Dermatology (AAD) on the Phase 3 ICONIC-LEAD study showed J&J's oral IL-23 inhibitor (icotrokinra) was superior to PLACEBO (not deucravacitinib as reported) in skin clearance (65% vs 8%) & PASI90 (50% v 4%) at Wk 16 (NOT 15) in 684 moderate-to-severe plaque PsO pts https://buff.ly/dMbTbML
More shows like Rheumnow Podcast
View all
AFP: American Family Physician Podcast
701 Listeners
JAMA Clinical Reviews
504 Listeners
Frankly Speaking About Family Medicine
264 Listeners
The Curbsiders Internal Medicine Podcast
3,374 Listeners
Core IM | Internal Medicine Podcast
1,150 Listeners
The Evidence Based Rheumatology Podcast
122 Listeners
Healio Rheuminations
120 Listeners
Annals On Call Podcast
194 Listeners
The Clinical Problem Solvers
518 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
367 Listeners
ACR on Air
68 Listeners
Around the Rheum with Drs. Daniel Ennis & Janet Pope
5 Listeners
Rheumatology For The Royal College
183 Listeners
ACR Journals On Air
19 Listeners
Talking Rheumatology Spotlight
6 Listeners